Sales and Marketing

US-based cell and gene therapy (CGT) company ElevateBio has announced that, at the end of its Series D financing led …

UK-based life sciences and immunodiagnostics firm Oncimmune Holdings has announced that it has sold its Oncimmune Limited and Oncimmune Europe …

US-based clinical-stage company Nido Biosciences has announced that is has received $109m in Seed, Series A and Series B financings, …

uniQure has announced that it has entered a definitive agreement to sell a portion of the royalty rights due to …

Angelini Pharma and JCR Pharmaceuticals have announced that they have entered into an exclusive global development and commercialisation agreement for …

Gilead Sciences has announced the acquisition of all outstanding shares of XinThera, a privately-owned biotech company based in San Diego, …

Maze Therapeutics and Sanofi have announced that they have signed an exclusive worldwide license agreement for Maze’s gluogen synthase 1 …

Pfizer has announced that the US Food and Drug Administration (FDA) has approved its PREVNAR 20 (20-valent pneumococcal conjugate vaccine) …

US-based rare medicines pharmacy PANTHERx Rare has announced the launch of Cuvrior, a treatment for stable Wilson Disease in adults …

Acadia Pharmaceuticals has announced that Daybue (trofinetide) is now available for adult and paediatric patients over the age of two …

Private biotech company Ariceum Therapeutics has announced the successful completion of Series A extension financing, raising an additional €22.75m following …

Merck (known as MSD outside of the US and Canada) has announced that it, through a subsidiary, has agreed to …

Irish medical device company Neuromod has announced that it has successfully closed a €30m financing intended to further commercialise Lenire, …

Copenhagen, Denmark, 13 April, 2023 – Adcendo ApS (“Adcendo”), a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) …

Alentis Therapeutics has announced $105m in Series C funding which was led by Jeito Capital together with Novo Holdings A/S …